General Elder Granger, age 67 years, is a U.S. Army Major General (Retired) and has served as the President and Chief Executive Officer of THE 5Ps, LLC, a healthcare, education, and leadership consulting firm, since August 2009. He served in the U.S. Army for over 35 years before retiring in June 2009 and was the Deputy Director and Program Executive Officer of TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from December 2005 to June 2009. He is board certified by the American College of Physician Executives, American College of Healthcare Executives, American Board of Medical Quality, and American Board of Internal Medicine, National Association of Corporate Directors, and holds numerous medical certifications. General Granger currently serves on the board of directors of Cigna Corporation (since 2018), Cerner Corporation (since 2020) and DLH Holdings Corp (since 2014), and he previously served on the board of directors of Express Scripts Holding Company (from 2015 to 2018). He received his Bachelor of Science Degree from Arkansas State University in 1976 and earned his medical degree from University of Arkansas School of Medicine in 1980.
General Granger has extensive experience in health care management and operations, including health policy, planning, budgeting, compliance, and execution related to the health program for uniformed service members around the globe. General Granger has unique leadership and policy experience through his career with the U.S. Army and the commercial sector.
What is Elder Granger's net worth?
The estimated net worth of Elder Granger is at least $14.40 as of May 16th, 2023. Dr. Granger owns 1,600 shares of Better Therapeutics stock worth more than $14 as of April 25th. This net worth approximation does not reflect any other investments that Dr. Granger may own. Learn More about Elder Granger's net worth.
How do I contact Elder Granger?
Has Elder Granger been buying or selling shares of Better Therapeutics?
Elder Granger has not been actively trading shares of Better Therapeutics during the last quarter. Most recently, on Tuesday, May 16th, Elder Granger bought 600 shares of Better Therapeutics stock. The stock was acquired at an average cost of $0.87 per share, with a total value of $522.00. Following the completion of the transaction, the director now directly owns 1,600 shares of the company's stock, valued at $1,392. Learn More on Elder Granger's trading history.
Who are Better Therapeutics' active insiders?
Are insiders buying or selling shares of Better Therapeutics?
During the last twelve months, Better Therapeutics insiders bought shares 5 times. They purchased a total of 1,699,462 shares worth more than $1,240,691.26. The most recent insider tranaction occured on July, 27th when Chairman David P Perry bought 1,233,045 shares worth more than $900,122.85. Insiders at Better Therapeutics own 51.4% of the company.
Learn More about insider trades at Better Therapeutics. Information on this page was last updated on 7/27/2023.